US · TIVC
Tivic Health Systems, Inc.
- Sector
- Healthcare · Medical - Devices
- Headquarters
- Fremont, CA 94545
- Website
- tivichealth.com
Price · as of 2024-12-31
—
Market cap 889.68K
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $30.57 | — |
| Intrinsic Value(DCF) | $1.49 | — |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | $0.47 | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | $0.00 | $0.00 | |||
| 2021 | $2,524.50 | $3,907.75 | $202.10 | $0.00 | $0.00 |
| 2022 | $357.00 | $333.94 | $465.12 | $0.00 | $0.00 |
| 2023 | $23.63 | $784.09 | $0.00 | $0.00 | $4,648.51 |
| 2024 | $3.72 | $30.57 | $0.00 | $0.00 | $0.47 |
AI valuation
Our deep-learning model estimates Tivic Health Systems, Inc.'s (TIVC) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $30.57
- Current price
- —
- AI upside
- —
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$1.49
— upside
Graham-Dodd
—
— upside
Graham Formula
$0.47
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| TIVC | Tivic Health Systems, Inc… | $0.82 | 889.68K | +3,622% | +81% | — | -43% | -189.04 | 421.70 | 1370.53 | -200.98 | — | 421.70 | 0.26% | -725.77% | -725.00% | -184.96% | -1041.58% | -142.01% | 0.00 | — | 9.70 | 7.61 | 0.38 | -8887.00% | -3367.00% | -3365.00% | -0.54% | -21.05 | -1053.36% | 0.00% | 0.00% | 0.00% | -188.49 | -186.38 | 1367.97 | 2331.04 |
| BJDX | Bluejay Diagnostics, Inc. | $2.05 | 929.76K | — | — | — | — | -0.10 | 0.13 | — | 0.49 | -0.17 | 0.13 | 0.00% | — | — | -178.98% | -533.23% | -133.92% | 0.04 | -8.71 | 6.05 | 5.33 | 0.61 | 5724.00% | — | -989.00% | -1057.58% | -9.65 | -604.40% | 0.00% | 0.00% | 289.45% | 0.46 | 0.41 | — | -9.61 |
| ELAB | PMGC Holdings Inc. | $1.19 | 126.21K | +401,467% | +24,631% | — | — | -0.06 | 0.06 | 0.16 | 1.12 | — | 0.10 | 72.84% | -75.65% | -253.14% | -119.12% | -110.26% | -88.07% | 0.00 | -2.54 | 3.36 | 2.22 | 1.25 | -8600.00% | 4407.00% | 2032.00% | -1366.73% | -3.05 | -324.66% | 0.00% | 0.00% | 215.87% | 1.92 | 0.65 | -1.45 | -1.81 |
| MLEC | Moolec Science S.A. | $13.30 | 9.66M | +7,515% | +24,189,467% | — | — | -0.07 | -0.12 | 0.02 | -3.56 | 0.00 | -0.05 | 34.17% | -3.14% | -33.41% | 376.84% | -11.15% | -93.08% | -3.74 | -0.25 | 0.13 | 0.12 | -3.57 | 897895.00% | 583074.00% | 21733.00% | -393.07% | -0.10 | -32.03% | 0.00% | 0.00% | 12.10% | -23.43 | -8.16 | 0.74 | -0.48 |
| NCEL | NewcelX Ltd. | $2.90 | 1.31M | — | — | — | — | -0.65 | 0.91 | — | 0.11 | -0.09 | 0.91 | 0.00% | — | — | 53.34% | 104.83% | -97.10% | 0.00 | -29.20 | 2.69 | 2.50 | 0.46 | 72188.00% | — | -5589.00% | -333.71% | -5.16 | 102.24% | 0.00% | 0.00% | 187.60% | 0.09 | 0.09 | — | -51.45 |
| PRFX | PRF Technologies Ltd. | $2.97 | 239.18K | — | — | — | — | -0.02 | 0.15 | — | 0.27 | — | 0.15 | 0.00% | — | — | -321.92% | 948.79% | -201.84% | 0.02 | -1048.07 | 1.81 | 1.79 | 0.29 | -8123.00% | — | 8891.00% | -4551.60% | -5.17 | 816.94% | 0.00% | 0.00% | 0.00% | 0.27 | 0.31 | — | -27.58 |
| UPC | Universe Pharmaceuticals … | $2.72 | 1.53M | +5,735,314% | +242,398% | +399,145% | +515,984% | 0.00 | 0.00 | 0.00 | 8.32 | — | 0.00 | 35.28% | -16.33% | -20.56% | -7.23% | -10.45% | -5.35% | 0.16 | -12.57 | 4.07 | 3.55 | 8.33 | -2649.00% | -2244.00% | -4529.00% | -37140.54% | -0.38 | -19.36% | 0.00% | 0.00% | 19477.17% | 8.34 | 4.50 | -1.36 | 0.54 |
| VRAX | Virax Biolabs Group Limit… | $0.23 | 988.66K | +58,899% | +71% | — | +71,836% | -0.50 | 0.53 | 478.92 | 0.14 | — | 0.54 | -838.21% | -97344.76% | -95739.17% | -109.69% | -313.42% | -101.88% | 0.07 | -105.93 | 7.27 | 6.33 | 0.66 | -4196.00% | -9595.00% | -3028.00% | -170.43% | -6.78 | -268.72% | 0.00% | 0.00% | 16.06% | 0.13 | 0.16 | -129.50 | -5.85 |
About Tivic Health Systems, Inc.
Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, including BestBuy.com and FSAStore.com. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.
- CEO
- Jennifer Ernst
- Employees
- 7
- Beta
- 1.98
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($1.49 ÷ —) − 1 = — (DCF, example).